Concepedia

Sanjay Ramakrishnan

SR

Statistics

Publications

11

Citations

1.4K

H-Index

11

Active since

2014

Affiliations

University of Oxford(Current)

National Institute for Health and Care Research

Edith Cowan University

Imperial College London

Oxford BioMedica (United Kingdom)

Sanjay Ramakrishnan is an author at University of Oxford specializing in pharmacotherapy, pulmonology, and respiratory disease.

Publications per year

2014–2024

11

Publications

11

Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial

Sanjay Ramakrishnan, Dan V. Nicolau, Beverly Langford et al. · The Lancet Respiratory Medicine · 2021 · 434 citations · Full text

Pharmacy, Clinical Sciences, Pharmacotherapy +13

Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial

Ly‐Mee Yu, Mona Bafadhel, Jienchi Dorward et al. · The Lancet · 2021 · 310 citations · Full text

Pharmacy, Community Medicine, Pharmacotherapy +14

Derivation of a prototype asthma attack risk scale centred on blood eosinophils and exhaled nitric oxide

Simon Couillard, Annette Laugerud, Maisha Jabeen et al. · Thorax · 2021 · 173 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +17

Treating eosinophilic exacerbations of asthma and COPD with benralizumab (ABRA): a double-blind, double-dummy, active placebo-controlled randomised trial

Sanjay Ramakrishnan, Richard Russell, Hafiz Taha Mahmood et al. · The Lancet Respiratory Medicine · 2024 · 103 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +12

Survival analysis of patients on maintenance hemodialysis

A Chandrashekar, Sanjay Ramakrishnan, DRangarajan Rangarajan · Indian Journal of Nephrology · 2014 · 100 citations · Full text

Medicine, Nephrology, Dialysis +13

1–5 of 11